UniProt ID | ELF1_HUMAN | |
---|---|---|
UniProt AC | P32519 | |
Protein Name | ETS-related transcription factor Elf-1 | |
Gene Name | ELF1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 619 | |
Subcellular Localization | Nucleus. | |
Protein Description | Transcription factor that activates the LYN and BLK promoters. Appears to be required for the T-cell-receptor-mediated trans activation of HIV-2 gene expression. Binds specifically to two purine-rich motifs in the HIV-2 enhancer.. | |
Protein Sequence | MAAVVQQNDLVFEFASNVMEDERQLGDPAIFPAVIVEHVPGADILNSYAGLACVEEPNDMITESSLDVAEEEIIDDDDDDITLTVEASCHDGDETIETIEAAEALLNMDSPGPMLDEKRINNNIFSSPEDDMVVAPVTHVSVTLDGIPEVMETQQVQEKYADSPGASSPEQPKRKKGRKTKPPRPDSPATTPNISVKKKNKDGKGNTIYLWEFLLALLQDKATCPKYIKWTQREKGIFKLVDSKAVSRLWGKHKNKPDMNYETMGRALRYYYQRGILAKVEGQRLVYQFKEMPKDLIYINDEDPSSSIESSDPSLSSSATSNRNQTSRSRVSSSPGVKGGATTVLKPGNSKAAKPKDPVEVAQPSEVLRTVQPTQSPYPTQLFRTVHVVQPVQAVPEGEAARTSTMQDETLNSSVQSIRTIQAPTQVPVVVSPRNQQLHTVTLQTVPLTTVIASTDPSAGTGSQKFILQAIPSSQPMTVLKENVMLQSQKAGSPPSIVLGPAQVQQVLTSNVQTICNGTVSVASSPSFSATAPVVTFSPRSSQLVAHPPGTVITSVIKTQETKTLTQEVEKKESEDHLKENTEKTEQQPQPYVMVVSSSNGFTSQVAMKQNELLEPNSF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
110 | Phosphorylation | EALLNMDSPGPMLDE HHHHCCCCCCCCCCH | 22.46 | 26074081 | |
126 | Phosphorylation | RINNNIFSSPEDDMV HCCCCCCCCCCCCEE | 40.98 | 25627689 | |
127 | Phosphorylation | INNNIFSSPEDDMVV CCCCCCCCCCCCEEE | 22.89 | 25627689 | |
160 | Phosphorylation | TQQVQEKYADSPGAS HHHHHHHHCCCCCCC | 18.19 | 23927012 | |
163 | Phosphorylation | VQEKYADSPGASSPE HHHHHCCCCCCCCCC | 19.64 | 29255136 | |
167 | Phosphorylation | YADSPGASSPEQPKR HCCCCCCCCCCCCCC | 52.95 | 29255136 | |
168 | Phosphorylation | ADSPGASSPEQPKRK CCCCCCCCCCCCCCC | 31.74 | 29255136 | |
180 | Phosphorylation | KRKKGRKTKPPRPDS CCCCCCCCCCCCCCC | 47.63 | 23927012 | |
187 | Phosphorylation | TKPPRPDSPATTPNI CCCCCCCCCCCCCCE | 21.08 | 25159151 | |
190 | Phosphorylation | PRPDSPATTPNISVK CCCCCCCCCCCEEEE | 46.28 | 25159151 | |
191 | Phosphorylation | RPDSPATTPNISVKK CCCCCCCCCCEEEEE | 19.22 | 23401153 | |
195 | Phosphorylation | PATTPNISVKKKNKD CCCCCCEEEEEECCC | 34.23 | 23401153 | |
197 | Ubiquitination | TTPNISVKKKNKDGK CCCCEEEEEECCCCC | 51.76 | - | |
226 | Ubiquitination | QDKATCPKYIKWTQR HCCCCCHHHCCCHHH | 62.85 | - | |
229 | Ubiquitination | ATCPKYIKWTQREKG CCCHHHCCCHHHCCC | 40.89 | - | |
231 | Phosphorylation | CPKYIKWTQREKGIF CHHHCCCHHHCCCEE | 16.85 | 22817900 | |
239 | Ubiquitination | QREKGIFKLVDSKAV HHCCCEEEEECHHHH | 45.76 | 21890473 | |
239 | Ubiquitination | QREKGIFKLVDSKAV HHCCCEEEEECHHHH | 45.76 | 21890473 | |
244 | Ubiquitination | IFKLVDSKAVSRLWG EEEEECHHHHHHHHC | 48.63 | - | |
256 | Ubiquitination | LWGKHKNKPDMNYET HHCCCCCCCCCCHHH | 47.39 | - | |
261 | Phosphorylation | KNKPDMNYETMGRAL CCCCCCCHHHHHHHH | 13.21 | - | |
269 | Methylation | ETMGRALRYYYQRGI HHHHHHHHHHHHCCC | 19.20 | - | |
270 | Phosphorylation | TMGRALRYYYQRGIL HHHHHHHHHHHCCCC | 13.84 | 28270605 | |
271 | Phosphorylation | MGRALRYYYQRGILA HHHHHHHHHHCCCCC | 6.16 | 28270605 | |
272 | Phosphorylation | GRALRYYYQRGILAK HHHHHHHHHCCCCCE | 5.25 | 28270605 | |
279 | Sumoylation | YQRGILAKVEGQRLV HHCCCCCEEECCEEE | 37.06 | - | |
279 | Sumoylation | YQRGILAKVEGQRLV HHCCCCCEEECCEEE | 37.06 | - | |
279 | Ubiquitination | YQRGILAKVEGQRLV HHCCCCCEEECCEEE | 37.06 | - | |
290 | Ubiquitination | QRLVYQFKEMPKDLI CEEEEEEECCCCCEE | 37.26 | 21890473 | |
290 | Ubiquitination | QRLVYQFKEMPKDLI CEEEEEEECCCCCEE | 37.26 | 21890473 | |
305 | Phosphorylation | YINDEDPSSSIESSD EECCCCCCCCCCCCC | 49.38 | 27690223 | |
306 | Phosphorylation | INDEDPSSSIESSDP ECCCCCCCCCCCCCC | 40.50 | 30576142 | |
307 | Phosphorylation | NDEDPSSSIESSDPS CCCCCCCCCCCCCCC | 34.41 | 30576142 | |
310 | Phosphorylation | DPSSSIESSDPSLSS CCCCCCCCCCCCCCC | 38.07 | 27690223 | |
311 | Phosphorylation | PSSSIESSDPSLSSS CCCCCCCCCCCCCCC | 40.53 | 27690223 | |
317 | Phosphorylation | SSDPSLSSSATSNRN CCCCCCCCCCCCCCC | 29.32 | 25627689 | |
318 | Phosphorylation | SDPSLSSSATSNRNQ CCCCCCCCCCCCCCC | 31.99 | 25627689 | |
329 | Phosphorylation | NRNQTSRSRVSSSPG CCCCCCCCHHCCCCC | 36.48 | 30576142 | |
332 | Phosphorylation | QTSRSRVSSSPGVKG CCCCCHHCCCCCCCC | 24.80 | 26055452 | |
333 | Phosphorylation | TSRSRVSSSPGVKGG CCCCHHCCCCCCCCC | 37.38 | 23401153 | |
334 | Phosphorylation | SRSRVSSSPGVKGGA CCCHHCCCCCCCCCC | 20.40 | 26055452 | |
342 | Phosphorylation | PGVKGGATTVLKPGN CCCCCCCEEEECCCC | 22.25 | 28122231 | |
343 | Phosphorylation | GVKGGATTVLKPGNS CCCCCCEEEECCCCC | 24.25 | 28122231 | |
346 | Acetylation | GGATTVLKPGNSKAA CCCEEEECCCCCCCC | 46.68 | 23749302 | |
350 | Phosphorylation | TVLKPGNSKAAKPKD EEECCCCCCCCCCCC | 29.59 | 23312004 | |
351 | Acetylation | VLKPGNSKAAKPKDP EECCCCCCCCCCCCC | 57.26 | 25953088 | |
354 | Acetylation | PGNSKAAKPKDPVEV CCCCCCCCCCCCCCC | 58.42 | 25953088 | |
354 | Ubiquitination | PGNSKAAKPKDPVEV CCCCCCCCCCCCCCC | 58.42 | - | |
370 | Phosphorylation | QPSEVLRTVQPTQSP CHHHHHHCCCCCCCC | 21.23 | 28450419 | |
374 | Phosphorylation | VLRTVQPTQSPYPTQ HHHCCCCCCCCCCCE | 25.29 | 28450419 | |
376 | Phosphorylation | RTVQPTQSPYPTQLF HCCCCCCCCCCCEEE | 28.95 | 25159151 | |
378 | Phosphorylation | VQPTQSPYPTQLFRT CCCCCCCCCCEEEEE | 24.94 | 28450419 | |
380 | Phosphorylation | PTQSPYPTQLFRTVH CCCCCCCCEEEEEEE | 31.87 | 28450419 | |
403 | O-linked_Glycosylation | PEGEAARTSTMQDET CCCCCCCCCCCCHHH | 24.67 | 30059200 | |
404 | O-linked_Glycosylation | EGEAARTSTMQDETL CCCCCCCCCCCHHHH | 19.14 | 30059200 | |
405 | O-linked_Glycosylation | GEAARTSTMQDETLN CCCCCCCCCCHHHHH | 20.45 | 30059200 | |
406 | Sulfoxidation | EAARTSTMQDETLNS CCCCCCCCCHHHHHH | 4.78 | 21406390 | |
413 | O-linked_Glycosylation | MQDETLNSSVQSIRT CCHHHHHHHHHHHEE | 34.69 | 30059200 | |
413 | Phosphorylation | MQDETLNSSVQSIRT CCHHHHHHHHHHHEE | 34.69 | 27251275 | |
414 | Phosphorylation | QDETLNSSVQSIRTI CHHHHHHHHHHHEEE | 24.09 | 28555341 | |
420 | Phosphorylation | SSVQSIRTIQAPTQV HHHHHHEEEECCCCC | 18.77 | 29396449 | |
425 | Phosphorylation | IRTIQAPTQVPVVVS HEEEECCCCCCEEEC | 45.26 | 26657352 | |
432 | Phosphorylation | TQVPVVVSPRNQQLH CCCCEEECCCCCEEE | 13.41 | 25159151 | |
440 | Phosphorylation | PRNQQLHTVTLQTVP CCCCEEEEEEEEECC | 24.63 | 24043423 | |
442 | Phosphorylation | NQQLHTVTLQTVPLT CCEEEEEEEEECCCE | 17.82 | 24043423 | |
445 | Phosphorylation | LHTVTLQTVPLTTVI EEEEEEEECCCEEEE | 27.49 | 24043423 | |
449 | Phosphorylation | TLQTVPLTTVIASTD EEEECCCEEEEEECC | 16.97 | 24043423 | |
450 | Phosphorylation | LQTVPLTTVIASTDP EEECCCEEEEEECCC | 20.00 | 24043423 | |
454 | Phosphorylation | PLTTVIASTDPSAGT CCEEEEEECCCCCCC | 23.40 | 24043423 | |
455 | Phosphorylation | LTTVIASTDPSAGTG CEEEEEECCCCCCCC | 42.79 | 24043423 | |
458 | Phosphorylation | VIASTDPSAGTGSQK EEEECCCCCCCCCCE | 41.98 | 24043423 | |
461 | Phosphorylation | STDPSAGTGSQKFIL ECCCCCCCCCCEEEE | 33.12 | 24043423 | |
463 | Phosphorylation | DPSAGTGSQKFILQA CCCCCCCCCEEEEEE | 29.99 | 22817901 | |
473 | O-linked_Glycosylation | FILQAIPSSQPMTVL EEEEECCCCCCCEEE | 35.18 | 30059200 | |
473 | Phosphorylation | FILQAIPSSQPMTVL EEEEECCCCCCCEEE | 35.18 | 27251275 | |
474 | O-linked_Glycosylation | ILQAIPSSQPMTVLK EEEECCCCCCCEEEE | 32.71 | 30059200 | |
474 | Phosphorylation | ILQAIPSSQPMTVLK EEEECCCCCCCEEEE | 32.71 | 17525332 | |
478 | O-linked_Glycosylation | IPSSQPMTVLKENVM CCCCCCCEEEEHHHH | 29.39 | 30059200 | |
478 | Phosphorylation | IPSSQPMTVLKENVM CCCCCCCEEEEHHHH | 29.39 | 27251275 | |
481 | Ubiquitination | SQPMTVLKENVMLQS CCCCEEEEHHHHHCC | 42.79 | - | |
488 | O-linked_Glycosylation | KENVMLQSQKAGSPP EHHHHHCCCCCCCCC | 29.68 | 30059200 | |
493 | O-linked_Glycosylation | LQSQKAGSPPSIVLG HCCCCCCCCCEEEEC | 38.20 | 30059200 | |
509 | O-linked_Glycosylation | AQVQQVLTSNVQTIC HHHHHHHHCCCCEEE | 21.28 | 30059200 | |
510 | O-linked_Glycosylation | QVQQVLTSNVQTICN HHHHHHHCCCCEEEC | 30.73 | 30059200 | |
514 | O-linked_Glycosylation | VLTSNVQTICNGTVS HHHCCCCEEECCEEE | 24.18 | 30059200 | |
519 | O-linked_Glycosylation | VQTICNGTVSVASSP CCEEECCEEEECCCC | 8.80 | 30059200 | |
521 | O-linked_Glycosylation | TICNGTVSVASSPSF EEECCEEEECCCCCC | 16.29 | 30059200 | |
525 | O-linked_Glycosylation | GTVSVASSPSFSATA CEEEECCCCCCCCCC | 18.15 | 30059200 | |
527 | O-linked_Glycosylation | VSVASSPSFSATAPV EEECCCCCCCCCCCE | 33.51 | 30059200 | |
529 | O-linked_Glycosylation | VASSPSFSATAPVVT ECCCCCCCCCCCEEE | 29.10 | 30059200 | |
531 | O-linked_Glycosylation | SSPSFSATAPVVTFS CCCCCCCCCCEEEEC | 30.23 | 30059200 | |
536 | O-linked_Glycosylation | SATAPVVTFSPRSSQ CCCCCEEEECCCHHH | 20.73 | 30059200 | |
536 | Phosphorylation | SATAPVVTFSPRSSQ CCCCCEEEECCCHHH | 20.73 | 26074081 | |
538 | Phosphorylation | TAPVVTFSPRSSQLV CCCEEEECCCHHHEE | 15.27 | 26074081 | |
541 | Phosphorylation | VVTFSPRSSQLVAHP EEEECCCHHHEEECC | 26.31 | 26074081 | |
542 | Phosphorylation | VTFSPRSSQLVAHPP EEECCCHHHEEECCC | 28.90 | 26074081 | |
547 (in isoform 2) | Ubiquitination | - | 22.93 | 20972266 | |
554 | Phosphorylation | HPPGTVITSVIKTQE CCCCCEEEEEEECHH | 16.77 | 22210691 | |
555 | Phosphorylation | PPGTVITSVIKTQET CCCCEEEEEEECHHC | 15.66 | 22210691 | |
558 | Acetylation | TVITSVIKTQETKTL CEEEEEEECHHCHHH | 41.84 | 25953088 | |
559 | Phosphorylation | VITSVIKTQETKTLT EEEEEEECHHCHHHH | 22.10 | - | |
562 | Phosphorylation | SVIKTQETKTLTQEV EEEECHHCHHHHHHH | 21.36 | 22210691 | |
564 | Phosphorylation | IKTQETKTLTQEVEK EECHHCHHHHHHHHH | 42.32 | 22210691 | |
566 | Phosphorylation | TQETKTLTQEVEKKE CHHCHHHHHHHHHHH | 28.10 | 17525332 | |
571 | Ubiquitination | TLTQEVEKKESEDHL HHHHHHHHHHCHHHH | 68.00 | 2097226 | |
618 | Phosphorylation | NELLEPNSF------ CCCCCCCCC------ | 42.94 | 30576142 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ELF1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ELF1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NFKB1_HUMAN | NFKB1 | physical | 7862168 | |
REL_HUMAN | REL | physical | 7862168 | |
NFKB1_HUMAN | NFKB1 | physical | 9094628 | |
HXC13_HUMAN | HOXC13 | physical | 18692240 | |
HPBP1_HUMAN | HSPBP1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-160; SER-163; SER-167;SER-187 AND SER-432, AND MASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-167, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-160; SER-163 ANDSER-168, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-163; SER-168 ANDSER-432, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-432, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-474 AND THR-566, ANDMASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-432, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168, AND MASSSPECTROMETRY. |